Remedium Lifecare (REMLIFE) | Financial Analysis & Statements
Remedium Lifecare Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
1.1B
Gross Profit
105.9M
9.53%
Operating Income
73.7M
6.64%
Net Income
86.2M
7.76%
EPS (Diluted)
₹0.10
Balance Sheet Metrics
Total Assets
17.2B
Total Liabilities
16.8B
Shareholders Equity
438.9M
Debt to Equity
38.20
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Remedium Lifecare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.1B | 40.4B | 5.1B | 5.0B | 900.3M |
| Cost of Goods Sold | 4.0B | 40.0B | 4.9B | 5.0B | 879.2M |
| Gross Profit | 71.2M | 403.3M | 159.8M | 63.1M | 21.1M |
| Gross Margin % | 1.8% | 1.0% | 3.1% | 1.3% | 2.3% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 17.4M | 12.3M | 36.8M | 12.7M | 5.3M |
| Other Operating Expenses | 21.1M | 29.6M | 19.7M | 23.4M | 3.8M |
| Total Operating Expenses | 38.5M | 41.9M | 56.5M | 36.1M | 9.2M |
| Operating Income | 12.3M | 341.5M | 85.7M | 17.4M | 6.6M |
| Operating Margin % | 0.3% | 0.8% | 1.7% | 0.3% | 0.7% |
| Non-Operating Items | |||||
| Interest Income | 1.3M | 0 | 755.0K | 0 | 0 |
| Interest Expense | 76.2M | 40.2M | 717.0K | 1.8M | 113.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 43.8M | 504.5M | 74.0M | 15.3M | 6.5M |
| Income Tax | 22.5M | 177.2M | 19.7M | 4.5M | 1.7M |
| Effective Tax Rate % | 51.4% | 35.1% | 26.6% | 29.3% | 26.4% |
| Net Income | 21.3M | 327.3M | 54.3M | 10.8M | 4.8M |
| Net Margin % | 0.5% | 0.8% | 1.1% | 0.2% | 0.5% |
| Key Metrics | |||||
| EBITDA | 120.4M | 545.1M | 91.6M | 17.7M | 7.2M |
| EPS (Basic) | ₹0.03 | ₹0.81 | ₹3.77 | ₹0.03 | ₹0.01 |
| EPS (Diluted) | ₹0.03 | ₹0.81 | ₹3.77 | ₹0.03 | ₹0.01 |
| Basic Shares Outstanding | 577654325 | 403200000 | 14400000 | 403200000 | 403200000 |
| Diluted Shares Outstanding | 577654325 | 403200000 | 14400000 | 403200000 | 403200000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Remedium Lifecare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 2.8M | 2.7M | 2.4M | 7.0M | 6.6M |
| Short-term Investments | 15.4M | 12.8M | 216.1M | 7.4M | 1.5M |
| Accounts Receivable | 7.7B | 9.2B | 1.7B | 640.0M | 236.8M |
| Inventory | 2.7B | 1.3B | 73.2M | 838.7M | 31.1M |
| Other Current Assets | -1.0K | 1.0K | -1.0K | -2.0K | -1.0K |
| Total Current Assets | 17.2B | 19.5B | 11.5B | 2.2B | 383.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 83.0K | 470.0K | 781.0K | 854.0K | 730.0K |
| Goodwill | 0 | 0 | 0 | 1.0M | 1.4M |
| Intangible Assets | - | - | - | 1.0M | 1.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -1.0K | 8.0K | - | -1.0K | -1.0K |
| Total Non-Current Assets | 441.0K | 737.0K | 855.0K | 1.9M | 2.1M |
| Total Assets | 17.2B | 19.5B | 11.5B | 2.2B | 385.3M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 5.0B | 7.1B | 842.2M | 1.2B | 237.7M |
| Short-term Debt | 449.4M | 577.0M | 0 | 0 | 0 |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 4.0M | 1.0M | 2.0M | 1.3M | 75.0K |
| Total Current Liabilities | 16.8B | 19.0B | 11.4B | 2.2B | 241.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 0 | 0 | 0 | 0 | 105.0M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 1.0K | 34.0K |
| Other Non-Current Liabilities | -1.0K | - | - | - | - |
| Total Non-Current Liabilities | -1.0K | 0 | 0 | 1.0K | 105.0M |
| Total Liabilities | 16.8B | 19.0B | 11.4B | 2.2B | 346.8M |
| Equity | |||||
| Common Stock | 403.2M | 100.8M | 36.0M | 36.0M | 36.0M |
| Retained Earnings | 35.7M | 328.8M | 65.5M | 11.2M | 417.0K |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 438.9M | 429.6M | 103.6M | 49.4M | 38.6M |
| Key Metrics | |||||
| Total Debt | 449.4M | 577.0M | 0 | 0 | 105.0M |
| Working Capital | 438.5M | 428.8M | 102.8M | 47.5M | 141.5M |
Balance Sheet Composition
Remedium Lifecare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 43.8M | 504.5M | 74.0M | 15.3M | 6.5M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -16.5B | -7.5B | 532.0M | -912.2M | -342.7M |
| Operating Cash Flow | -16.4B | -7.0B | 606.3M | -895.8M | -336.2M |
| Investing Activities | |||||
| Capital Expenditures | - | - | 0 | 0 | 0 |
| Acquisitions | 0 | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 1.3M | - | 0 | 0 | 0 |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 0 | 0 | 0 | 101.4M |
| Debt Repayment | - | 0 | 0 | -105.0M | - |
| Financing Cash Flow | 11.4B | 577.0M | 0 | -105.0M | 101.4M |
| Free Cash Flow | -11.4B | -741.6M | 204.6M | 112.3M | -102.5M |
| Net Change in Cash | -5.0B | -6.4B | 606.3M | -1.0B | -234.8M |
Cash Flow Trend
Remedium Lifecare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
6.54
Price to Book
0.71
Price to Sales
0.14
PEG Ratio
0.03
Profitability Ratios
Profit Margin
2.33%
Operating Margin
6.64%
Return on Equity
16.22%
Return on Assets
0.19%
Financial Health
Current Ratio
1.06
Debt to Equity
1,033.81
Beta
1.04
Per Share Data
EPS (TTM)
₹0.13
Book Value per Share
₹1.19
Revenue per Share
₹8.12
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| REMLIFE | 308.7M | 6.54 | 0.71 | 16.22% | 2.33% | 1,033.81 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.




